- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07655765
The Effect of Breastfeeding Education Using the Pecha Kucha Technique on Breastfeeding Self-Efficacy and Breastfeeding Success in the Early Postpartum Period: A Randomized Controlled Trial
13 juni 2026 bijgewerkt door: YASEMİN AYDIN KARTAL, Saglik Bilimleri Universitesi
Breast milk is considered the most biologically appropriate source of nutrition, essential for the healthy growth and development of newborns.
Thanks to its optimal nutrients, immunological factors, and growth regulators, it not only meets nutritional needs but also protects against infections, reducing neonatal morbidity and mortality rates.
The Pecha Kucha presentation technique keeps presentations concise and dynamic, creating a fast-paced, light, and engaging experience.
It minimizes distractions and maximizes engagement.
Because there is no text to read in the Pecha Kucha technique, presenters are required to be more prepared and strive to create a coherent narrative, resulting in a flawless narrative.
Thus, the aim is to ensure the success and effectiveness of breastfeeding education with this technique, and ultimately, to promote breastfeeding education using the Pecha Kucha technique to healthcare professionals.
The population of this randomized, controlled experimental study consists of primiparous postpartum women who gave birth in the Obstetrics Department of the Physical Therapy Annex Building of the Gaziosmanpaşa Training and Research Hospital at the University of Health Sciences.
A power analysis was conducted using the G*Power package program, Version 3.1.9.4, to determine the sample size of the study.
Because no similar research was found in the literature, Cohen's medium effect size was chosen as the effect size, anticipating that tests assessing the difference between two independent groups would be used when examining the differences in variables between the control and intervention groups.
Accordingly, with 64 participants in the control group and 64 in the intervention group, a power of 80% was calculated at a significance level of 0.5 (medium) effect size and 0.05, and a minimum sample size of 128 was determined.
The study, planned using an experimental design, is planned to be conducted on two groups: an intervention and a control group.
Within the scope of the study, pretest data will be collected by administering the Breastfeeding Self-Efficacy Scale and the LATCH Breastfeeding Diagnostic and Assessment Scale, along with an introductory information form, to postpartum women who agree to participate in the study.
Studie Overzicht
Studietype
Ingrijpend
Inschrijving (Geschat)
128
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studiecontact
- Naam: Yasemin, AYDIN KARTAL, Prof. Dr.
- Telefoonnummer: (0216) 777 87 77
- E-mail: yasemin.aydin@sbu.edu.tr
Studie Contact Back-up
- Naam: Merve N KAYADUMAN, Midwife
- Telefoonnummer: (0216) 777 87 77
- E-mail: merve.kydmn@gmail.com
Studie Locaties
-
-
-
Istanbul, Turkije (Türkiye)
- Sağlık Bilimleri Üniversitesi, İstanbul,
-
Contact:
- Merve N KAYADUMAN, Midwife
- Telefoonnummer: (0216) 777 87 77
- E-mail: merve.kydmn@gmail.com
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Ja
Beschrijving
Inclusion Criteria:
- - Being primiparous
- Having a full-term, singleton birth
- Having a healthy newborn
- Having a spontaneous vaginal birth
Exclusion Criteria:
- Being multiparous (having given birth more than once)
- Having given birth preterm or postterm
- Having a mother or newborn with health problems
- Having had a multiple pregnancy
- Having had a cesarean section
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: intervention group
Mothers in the intervention group will receive breastfeeding training using the Pecha Kucha presentation technique at the first hour postpartum
|
Training will be provided using training material consisting of 20 slides, each lasting 20 seconds, prepared using the 'Pecha Kucha' technique, for a total duration of 6 minutes and 20 seconds.
|
|
Geen tussenkomst: control group
Standard breastfeeding education, as part of the routine postpartum care practices of the Ministry of Health, will be given to the puerperal women in the control group at the first hour postpartum.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
introductory information form
Tijdsspanne: 10 minitus
|
This form, created by researchers based on literature, includes questions about the participants' age, high school graduation, their self-sufficiency against disasters, etc.
|
10 minitus
|
|
Breastfeeding Self-Efficacy Scale
Tijdsspanne: 10 minutes
|
The Breastfeeding Self-Efficacy Scale was developed by the National Institutes of Health (NIH) to assess mothers' breastfeeding self-efficacy levels.
The initial form consisted of 33 items.
In 2003, the scale was shortened to a 14-item version.Dennis recommends using the short form.
The Breastfeeding Self-Efficacy Short Form Scale is a 5-point Likert-type scale (1 = Not at all confident and 5 = Always confident).
The lowest possible score is 14, and the highest is 70.
As the score increases, breastfeeding self-efficacy also increases.
The validity and reliability of the scale in Turkey were conducted by Aluş Tokat, Okumus, and Dennis (2010).
The scale is a 5-point Likert-type scale, with scores ranging from Not at all confident (1 point) to Always confident (5 points).
The minimum possible score is 14, and the maximum score is 70.
There is no cut-off point for the scale.
A higher score indicates higher breastfeeding self-efficacy.
The Cronbach's alpha for the scale was found to be0.87
|
10 minutes
|
|
Latch Breastfeeding Diagnostic and Assessment Scale
Tijdsspanne: 10 minutes
|
The LATCH Breastfeeding Diagnostic Measurement Tool was developed by Jensen and colleagues (1994).
LATCH is a diagnostic tool created by simulating the Apgar scoring system in terms of its scoring method.
It is a quick and easy scale to evaluate (Jensen, Wallace 1994).
The Turkish validation of the tool was conducted by Demirhan in 1997, Koyun in 2001, and Yenal and Okumuş in 2003, and it was recommended as a reliable tool.
The lowest score obtained from the scale is 0, and the highest is 10.
A higher score indicates breastfeeding success.
The Cronbach's alpha value of the LATCH Breastfeeding Diagnostic Measurement Tool was found to be 0.95 by Yenal and Okumuş.
|
10 minutes
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Geschat)
13 juni 2026
Primaire voltooiing (Geschat)
1 juli 2026
Studie voltooiing (Geschat)
1 december 2026
Studieregistratiedata
Eerst ingediend
13 juni 2026
Eerst ingediend dat voldeed aan de QC-criteria
13 juni 2026
Eerst geplaatst (Werkelijk)
18 juni 2026
Updates van studierecords
Laatste update geplaatst (Werkelijk)
18 juni 2026
Laatste update ingediend die voldeed aan QC-criteria
13 juni 2026
Laatst geverifieerd
1 juni 2026
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- SBU-AYDINKARTAL-KAYADUMAN
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
NEE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .